XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Interim Condensed Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Dec. 25, 2020
Dec. 27, 2019
Revenue:    
Revenue $ 389,874 $ 291,877
Total revenue 389,874 291,877
Cost of revenue:    
Total cost of revenue 35,304 37,315
Gross margin 354,570 254,562
Operating expenses:    
Research and development 63,772 57,650
Sales and marketing 75,445 95,118
General and administrative 54,454 52,529
Gain on sale of assets (13,871) 0
Restructuring charges 10,023 675
Total operating expenses 189,823 205,972
Operating income 164,747 48,590
Other income/expense:    
Interest income 974 4,932
Interest expense (85) (72)
Other income, net 1,326 1,004
Total other income 2,215 5,864
Income before income taxes 166,962 54,454
Provision for income taxes (24,272) (5,863)
Net income including controlling interest 142,690 48,591
Less: net (income)/loss attributable to controlling interest (7,492) 162
Net income attributable to Dolby Laboratories, Inc. $ 135,198 $ 48,753
Net income per share:    
Basic (in usd per share) $ 1.34 $ 0.49
Diluted (in usd per share) $ 1.30 $ 0.47
Weighted-average shares outstanding:    
Basic (in shares) 100,716 100,336
Diluted (in shares) 103,876 103,078
Related party rent expense:    
Included in operating expenses $ 16 $ 70
Included in net income attributable to controlling interest $ 119 $ (106)
Common stock, dividends declared (in dollars per share) $ 0.22 $ 0.22
Common Stock, Dividends, Per Share, Cash Paid $ 0.22 $ 0.22
Licensing    
Revenue:    
Revenue $ 373,005 $ 257,683
Cost of revenue:    
Cost of revenue 12,946 12,342
Products and services    
Revenue:    
Revenue 16,869 34,194
Cost of revenue:    
Cost of revenue $ 22,358 $ 24,973